Kelly Smales serves as Executive at Transphorm, Inc., where they oversee executive responsibilities. Since joining the company, Kelly Smales has executed 18 insider transactions totaling $79.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 20, 2024 involved selling 69,677 shares valued at $0.
Kelly Smales currently holds 69,677 shares of Transphorm, Inc. (TGAN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kelly Smales has been a net seller of TGAN stock. They have purchased $0 and sold $79.5K worth of shares.
Kelly Smales's most recent insider trade was on Jun 20, 2024, when they sold 69,677 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $4.89 |
| Planned |
| Apr 24, 2024 | TGAN | $2.3K | Sale | 475 | $4.85 | Planned |
| Apr 20, 2024 | TGAN | $0 | Award | 1,356 | $N/A | Discretionary |
| Apr 4, 2024 | TGAN | $3.8K | Sale | 766 | $4.90 | Planned |
| Feb 28, 2024 | TGAN | $19.2K | Sale | 3,996 | $4.81 | Planned |
| Jan 24, 2024 | TGAN | $2.3K | Sale | 471 | $4.82 | Planned |
| Jan 20, 2024 | TGAN | $0 | Award | 1,345 | $N/A | Discretionary |
| Jan 4, 2024 | TGAN | $3.0K | Sale | 766 | $3.90 | Planned |
| Jan 2, 2024 | TGAN | $7.9K | Sale | 2,187 | $3.61 | Planned |
| Nov 22, 2023 | TGAN | $10.5K | Sale | 3,995 | $2.63 | Planned |
| Nov 20, 2023 | TGAN | $1.9K | Sale | 656 | $2.89 | Planned |
| Nov 17, 2023 | TGAN | $9.1K | Sale | 3,227 | $2.82 | Planned |
| Oct 20, 2023 | TGAN | $0 | Award | 2,708 | $N/A | Discretionary |
| Oct 11, 2023 | TGAN | $0 | Award | 2,968 | $N/A | Discretionary |
| Oct 11, 2023 | TGAN | $0 | Award | 45,662 | $N/A | Discretionary |
| Jul 21, 2023 | TGAN | $3.9K | Option Exercise | 1,173 | $3.30 | Discretionary |
| Jul 1, 2021 | TGAN | $0 | Award | 35,000 | $N/A | Discretionary |